HUBUNGAN IMUNOTERAPI DOSIS ESKALASI TERHADAP PERUBAHAN RASIO IL-4 IFN-Y DAN PERBAIKAN GEJALA KLINIK PENDERITA RINITIS ALERGI - Diponegoro University | Institutional Repository (UNDIP-IR)

55

DAFTAR PUSTAKA
1. Kay AB. Mechanism and treatment of allergic rhinitis. In: Kerr AG, editor.
ScottBrown’s Otolaryngology Rhinology. Fifth ed. London: Butterworth,
1987:93-8
2. Durham SR. Mechanisms and treatment of allergic rhinitis. In: Kerr AG, editor.
Scott Brown's Otolaryngology Rhinology. Sixth ed. Oxford: Butterworth, 1997
: 461-3
3.

Nathan RA, Mestzer EO, Selner JC, Stroms W. Prevalence of allergic rhinitis in
the United States. J Allergy Clin Immunol 1997; 99 Suppl: 808-14

4. Ishizaka K and Ishizaka T. Alergy In: William E P. Fundamental Imunology.
2nd ed. Raven Press New York.: 867-88
5. Sumarman I.Strategi Pengobatan Rasional Rinitis Alergi Perenial: Ditinjau dari
aspek biomolekuler reaksi inflamasi alergi. Konas Perhati. Semarang.1999:16177
6. Sumarman I. Respon seluler dan humoral reaksi alergi dalam mukosa hidung.
Dalam kursus penyegar penanggulangan penyakit alergi bidang THT,
Pertemuan Ilmiah Tahunan Bukittinggi 1993; 14-18

7. Sheikh J.Rhinitis Allergic.[On line]: http:// www.emedicine.com/med/topic 104
8. Suprihati, Nina I, Madiapura T, Sumarman I. Penatalaksanaan rinitis alergi
sesuai WHO-ARIA. BALI. Konggres Nasional XIII PERHATI-KL . 2003; 23:
68-75
9. Bousquet J. World Health Organisation initiative ARIA. A pocket guide for
physicians and nurses;1-21
10. Van Cauwenberge P, Bachert C, Passalacqua G,Bousquet J. Consensus
statement on the treatment of allergic rhinitis. Allergy 2000;55:116-34
11. Creticos. The consideration of immunotherapy in the treatment of allergyc
asthma. J Allergy Clin Immuno 2000;105:S 559-74
12. Bruce C, Gordon.Immunotherapy basics. Otolaryngol head and neck surg
1995;113:597-602

13. Bellinghausen I, Brand U, Enk AH, Knop J, Saloga J. Signals involved in the
early Th1/Th2 polarization of an immune response depending on the type of
antigen . J Allergy Clin Immunol 1999;103:298-306

56

14. Akdis CA, Blaser K. Mechanisms of allergen specific immunotherapy. Allergy

2000;55:522-30
15. Haugaard L. Immunologic effect of immunotherapy. Allergy 1999;54:S58 5658
16. Benjaponpitak S, Oro A, Maguire P, Marinkovich V, De kruyff R. The kinetics
of change in cytokine production by CD4+T cells during convensional allergen
immunotherapy. J Allergy Clin Immunol 1999;103:468-75
17. Lambrecht BN. Allergen uptake and presentation by dendritic cell. Current
Opinion In Allergy and clinical immunology 2001;1:51-59
18. Von Bubnoff D. Geiger E, Bieber Thomas. Antigen presenting cells in allergy.
J Allergy Cl in Immunol 2001;108 (3):329-39
19. Baraniuk JN. Pathogenesis of Allergic Rhinitis. J Allergy Clin Immunol
1997;99:S763-72
20. Abbas AK, Lichtman AH.B cell activation and antibody production. In:
Celluler and moleculer immunology, Fifth edition. Philadelphia :WB Saunders
Company.2003; 189-206
21. Abbas AK, Lichtman AH. Effector mechanism of immune responses. In :
Celluler and moleculer immunology. Fifth edition. Philadelphia: WB Saunders
Company 2003; 241-73
22. Constant SL, Kim B. Induction of Th-1 and Th-2 CD4+ T cell responses.
Annu.Rev.Immunol.1997.15:297-322
23. Leonard WJ. Type I cytokines and interferons and their receptor. In : Paul WE,

editor. Fundamental Imunology. Fifth edition. Philadelphia. Lippincott William
& Wilkins; 2003.p.701-35
24. Ryan J. IL-4 and it's reseptor essensial mediator of the allergic response.
J Allergy Clin Immunol.1997:99:1-5
25. Umetsu DT, De Kruyff RH. Th1 and Th2 CD4+ cells in human allergic
diseases. J Allergy Clin Immunology 1997:100:1-5
26. Boehm U, Klamp T, Groot M, Howard J.C. Cellular responses to interferonAnnu.Rev.Immunol.1997.15:749-95
27. Haydon III RC, Gordon BR. Aeroallergen immunotherapy. In: Krouse JH,
Chadaric SJ, Gordon BR, Dereby MJ (Eds). Allergy and Immunology an
otolaryngic approach. Philadelphia: Lippincott William & Wilkins 2002;152-82

57

28. Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy-therapeutic
vaccines for allergic diseases. Annals of allergy, asthma and immunology
1998;81:401-5.
29. Moeliawan H. Imunoterapi praktis. Surabaya. Pertemuan Ilmiah Paru Milenium
2002. 2002;11-22
30. Brunet C, Bedard PM, Lavoie A, Jobin M, Hebert J. Allergic rhinitis to ragweed
pollen. J Allergy Clin Immunol 1992;89:76-8

31. Peng Z, Naclerio R, Norman P, Adkinson F.Quantitive Ig E and IgG subclass
responses during and after long term ragweed immunotherapy. J Allergy Clin
Immunol 1992;89: 519-29
32. Till SJ, Francis JN, Aria KN, Durham SR. Mechanisms of immunotherapy.
J Allergy Clin Immunol 2004;113:1025-34
33. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in
IL-12 messenger RNA cells accompany inhibition of allergen-induced late skin
responses after successful grass pollen immunotherapy. J Allergy Immunol
1997;99:254-60.
34.Klimek L, Dorman D, Jarman ER, Cromwell O, Riechelmann H, Reske-Kunz
AB. Short-term preseasonal birch pollen allergoid immunotherapy influences
symptoms, specific nasal provocation and cytokines levels in nasal secretions,
but not peripheral T-cell responses, in patients with allergic rhinitis. Clin Exp
Allergy 1999;29:1326-1335.
35Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH.
Perkiraan besar sampel . Dalam : Sastroasmoro S, Ismael S, editor. Dasar-dasar
metodologi penelitian klinis. Edisi ke 2. Jakarta. Sagung Seto:2002.p.259-86
36 Choi SI, koh YI. Therapeutic effects of BCG vaccination in adult asthmatic
patients: a randomized controlled trial. Ann Allergy Asthma Immunol 2002;
88:584-91.

37.Bertrand B, Jamart J, Marchal JL, Arendt C. Cetirizine and pseudoephedrine
retard alone and in combination in the treatment of perennial allergic rhinitis; A
double blind multicentre study. Rhinology 1996; 34:91-6
38.Larche M, Robinson DS, Kay B. The role of T lymphocytes in the patogenesis
of asthma. J Allergy Clin Immunol 2003;111:450-63
39.Shi HZ, Qin XJ. CD4+CD25+ regulatory T lymphpcytes in allergy and asthma.
Allergy 2005;60(8):986-95